Sirnaomics Ltd. (HKG:2257)

Market Cap	712.20M +115.3%
Revenue (ttm)	n/a
Net Income	-112.10M
EPS	-1.19
Shares Out	108.90M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,500
Average Volume	187,060
Open	6.47
Previous Close	6.41
Day's Range	6.25 - 6.60
52-Week Range	2.83 - 22.78
Beta	-0.09
RSI	52.49
Earnings Date	Mar 27, 2026

About Sirnaomics

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP122G for the treatment of coagulation disorders;...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 52
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2257

Financial Performance

Financial numbers in USD